Literature DB >> 8141593

Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.

J M Crance1, F Lévêque, E Biziagos, H van Cuyck-Gandré, A Jouan, R Deloince.   

Abstract

Glycyrrhizin (GL) achieved a concentration-dependent inhibition of the replication of hepatitis A virus (HAV) in PLC/PRF/5 cells. GL has been shown to inhibit an early stage of the HAV replication. GL was not virucidal and had no measurable effect on the adsorption of [3H]uridine-labelled virions to cells. GL inhibited HAV penetration of the plasma membrane as measured by the amount of infective virus no longer neutralizable by specific antibody over time.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8141593     DOI： 10.1016/0166-3542(94)90033-7

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


  22 in total

1.  Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats.

Authors:  J Y Wang; Q S Zhang; J S Guo; M Y Hu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.

Authors:  Ka Ian Tam; Michael R Roner
Journal:  Antiviral Res       Date:  2011-04-23       Impact factor: 5.970

Review 3.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

4.  Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis.

Authors:  Shin Yasui; Keiichi Fujiwara; Akinobu Tawada; Yoshihiro Fukuda; Masayuki Nakano; Osamu Yokosuka
Journal:  Dig Dis Sci       Date:  2011-06-17       Impact factor: 3.199

5.  Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.

Authors:  Xiao-Ling Guo; Bo Liang; Xue-Wei Wang; Fu-Gang Fan; Jing Jin; Rui Lan; Jing-Hui Yang; Xiao-Chun Wang; Lei Jin; Qin Cao
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

6.  Glycyrrhizin as antiviral agent against Hepatitis C Virus.

Authors:  Usman A Ashfaq; Muhammad S Masoud; Zafar Nawaz; Sheikh Riazuddin
Journal:  J Transl Med       Date:  2011-07-18       Impact factor: 5.531

7.  A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation.

Authors:  Chao-Hung Hung; Kwong-Ming Kee; Chih-Hung Chen; Po-Lin Tseng; Ming-Chao Tsai; Chien-Hung Chen; Jing-Houng Wang; Kuo-Chin Chang; Yuan-Hung Kuo; Yi-Hao Yen; Tsung-Hui Hu; Sheng-Nan Lu
Journal:  Clin Transl Gastroenterol       Date:  2017-06-29       Impact factor: 4.488

8.  Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.

Authors:  Ruyi Gao; Yongshuai Zhang; Yuhui Kang; Weiyin Xu; Luyao Jiang; Tingting Guo; Changchao Huan
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

9.  In vitro inhibitory activity against HPV of the monoterpenoid zinc tetra-ascorbo-camphorate.

Authors:  Ralph Sydney Mboumba Bouassa; Bernard Gombert; Gabin Mwande-Maguene; Aurèle Mannarini; Laurent Bélec
Journal:  Heliyon       Date:  2021-06-06

10.  Antiviral activity of glycyrrhizin against hepatitis C virus in vitro.

Authors:  Yoshihiro Matsumoto; Tomokazu Matsuura; Haruyo Aoyagi; Mami Matsuda; Su Su Hmwe; Tomoko Date; Noriyuki Watanabe; Koichi Watashi; Ryosuke Suzuki; Shizuko Ichinose; Kenjiro Wake; Tetsuro Suzuki; Tatsuo Miyamura; Takaji Wakita; Hideki Aizaki
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.